文献速递心律失常心力衰竭与心肌病

生物学基质修饰抑制慢性缺血性心肌病猪模型室性心律失常

Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy.
PubMed 文献 · Eur Heart J · 2022-01-01

在易发室性心律失常的缺血性心肌病猪模型中,将心脏球来源细胞分泌的外泌体注射到电解剖标测确定的缓慢传导区,可减少瘢痕、抑制缓慢传导通路并减少程序电刺激诱发的室性心律失常。体外共培养实验证实其抗纤维化作用,提示外泌体注射可能成为替代传统消融的非破坏性疗法。

要点

  • 外泌体注射减少缺血性心肌病猪模型心肌瘢痕
  • 外泌体抑制缓慢传导通路并减少室性心律失常诱发
  • 抗纤维化作用在体外共培养实验中得到验证

核心结论

  • 注射心脏球来源细胞分泌的外泌体可能作为非破坏性替代方案用于预防复发性室性快速性心律失常。

研究设计与样本

  • 在易发室性心律失常的缺血性心肌病猪模型中,将心脏球来源细胞分泌的外泌体或赋形剂注射到电解剖标测确定的缓慢传导区。
  • 注射后随访至1个月,评估瘢痕、缓慢传导通路和程序电刺激诱发的室性心律失常。
  • 基于磁共振图像的电子重建模拟电活动,并用共培养实验验证抗纤维化作用。

主要发现

  • 注射后至1个月,外泌体组(而非赋形剂组)减少心肌瘢痕、抑制缓慢传导通路并减少程序电刺激诱发的室性心律失常。
  • 基于磁共振图像的电子重建准确再现了外泌体对室性心律失常诱发性的抑制作用。
  • 组织学和蛋白质组学分析显示外泌体具有强抗纤维化作用,并在心肌细胞与成纤维细胞共培养实验中得到证实。

临床怎么用

  • 外泌体注射可能作为传统消融的非破坏性替代策略,用于预防复发性室性快速性心律失常。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Cardiomyopathy patients are prone to ventricular arrhythmias (VA) and sudden cardiac death. Current therapies to prevent VA include radiofrequency ablation to destroy slowly conducting pathways of viable myocardium which support re-entry. Here, we tested the reverse concept, namely that boosting local tissue viability in zones of slow conduction might eliminate slow conduction and suppress VA in ischaemic cardiomyopathy. METHODS AND RESULTS: Exosomes are extracellular vesicles laden with bioactive cargo. Exosomes secreted by cardiosphere-derived cells (CDCEXO) reduce scar and improve heart function after intramyocardial delivery. In a VA-prone porcine model of ischaemic cardiomyopathy, we injected CDCEXO or vehicle into zones of delayed conduction defined by electroanatomic mapping. Up to 1-month post-injection, CDCEXO, but not the vehicle, decreased myocardial scar, suppressed slowly conducting electrical pathways, and inhibited VA induction by programmed electrical stimulation. In silico reconstruction of electrical activity based on magnetic resonance images accurately reproduced the suppression of VA inducibility by CDCEXO. Strong anti-fibrotic effects of CDCEXO, evident histologically and by proteomic analysis from pig hearts, were confirmed in a co-culture assay of cardiomyocytes and fibroblasts. CONCLUSION: Biological substrate modification by exosome injection may be worth developing as a non-destructive alternative to conventional ablation for the prevention of recurrent ventricular tachyarrhythmias.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Dawkins JF, Ehdaie A, Rogers R, et al. Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy. Eur Heart J. 2022. PMID: 35262692. doi:10.1093/eurheartj/ehac042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。